Anatomic Stage IV Breast Cancer AJCC v8 Not Yet Recruiting Phase 1 Trials for Lorcaserin (DB04871)

IndicationStatusPhase
DBCOND0109665 (Anatomic Stage IV Breast Cancer AJCC v8)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04205071Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast CancerTreatment